These DNA Startups Want to Put Your Whole Genome on the Blockchain

In 2018, people started using the blockchain to battle deepfakes, track sushi-grade tuna from Fiji to Brooklyn, and even cast a (symbolic) vote. It was only a matter of time before someone figured out how to put all 6 billion bits of your genetic source code on the blockchain too. Starting this week, a startup called Nebula Genomics is doing just that, offering whole-genome sequencing for free, as a way to stock up for its real ploy: a blockchain-based genetic marketplace.

Of course, nothing is free free. But if you’re willing to cough up some health information and refer your friends, you can earn special Nebula tokens that can help pay for a lo-fi sequence, the equivalent of a first draft that someone went over once with a subpar spell-checker. If you don’t want to answer survey questions about your donut and negroni habits or your family’s history of heart disease, you can get the same quick-and-dirty sequence for $99. But if you do answer the questions, and if a researcher or pharmaceutical company finds them interesting, they might pay to upgrade you to the Cadillac of whole genomes (what’s called 30x coverage, in the gene biz). In exchange, you grant them permission to study your data.

This offer comes bundled with all the promises of security, anonymity, and transparency (and money!) at the core of the blockchain’s immutable ledger. Once users have their genome sequenced, they can charge a fee, in tokens, to anyone who wants to access it. In the future, those tokens can be redeemed for additional tests and products that will further interpret your DNA.

you could look here
you could try here
you could try these out
you could try this out
your domain name
your input here
have a peek at this web-site
Source
have a peek here
Check This Out
this contact form
navigate here
his comment is here
weblink
check over here
this content
have a peek at these guys
check my blog
news
More about the author
click site
navigate to this website
my review here
get redirected here
useful reference
this page
Get More Info
see here
this website
great post to read
my company
imp source
click to read more
find more info
see it here
Homepage
a fantastic read
find this
Bonuses
read this article
click here now
browse this site
check here
original site
my response
pop over to these guys
my site
dig this
i thought about this
check this link right here now
his explanation
why not try these out
more info here
official site
look at this site
check it out
visit
click for more info
check these guys out
view publisher site
Get More Information
you can try this out
see this
learn this here now
directory
why not find out more
navigate to these guys
see this here
check my site
anchor
other
additional hints
look at this web-site
their explanation
internet
find more
Read More Here
here
Visit Website
hop over to this website
click
her latest blog
This Site
read review
try here
Clicking Here
page
read this post here
More Bonuses
recommended you read
go to this web-site
this
check that

Users also retain more control over their data than is typical. Anyone who’s been granted access to an individual’s de-identified DNA can only crunch analyses on that data using Nebula’s own computers. Buyers get to see the results, never the raw data itself. The only person who can download DNA data from the platform is the person whose DNA it is. The goal, says Nebula co-founder and chief scientific officer Dennis Grishin, is to create an environment where users can cheaply learn about their DNA and share it with scientists, while protecting themselves from potential privacy breaches.

The field of DNA testing has long been stuck with a circular problem. With whole genome sequences running about $1,000 each, the tests are so expensive, and the privacy concerns serious enough, that adoption has been slow. Further, only about two percent of people who get sequenced will turn up any information that could help them treat or stave off potential health risks. Your DNA could tell you more, if scientists had more genomes to work with. But the incentives for individuals just aren’t there yet.

This entrenched chicken-and-egg situation is the reason the federal government is spending $4 billion to sequence and study a million people across the US, asking them to donate their blood and spit and, eventually, giving them their results for just the price of participation. Now Nebula is joining the trend with its freemium approach.

Leave a Reply

Your email address will not be published. Required fields are marked *